Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangaram B&F is a South Korean biotechnology and functional food company specializing in the development of bioactive ingredients for health and nutrition. The company focuses on the fermentation of natural products, such as rice bran, using mushroom mycelium to enhance the solubility and efficacy of bioactive compounds like beta-glucan. Their research demonstrates significant immunomodulatory effects, including the stimulation of natural killer (NK) cell activity and the regulation of cytokine expression such as Interferon gamma and Interleukin-12. Hangaram B&F provides a variety of functional raw materials and processed food products, including low-calorie spreads and health supplements. The company operates in collaboration with academic institutions like Hannam University and industry partners to advance its R&D programs. Hangaram B&F is committed to improving human health through scientifically-validated nutritional solutions and innovative fermentation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on hangarambnf.